Effects of Intracoronary Nicorandil on Myocardial Microcirculation and Clinical Outcomes in Patients with Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials

Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

(2018) Chunguang Feng et al.   Heart Lung and Circulation

Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction

(2018) Qi Qi et al.   MEDICAL SCIENCE MONITOR

Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention

(2017) Zhihua Pang et al.   MEDICAL SCIENCE MONITOR

Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: A randomized factorial trial

(2015) CHUNHONG CHEN et al.   Experimental and Therapeutic Medicine

Usefulness of Transient and Persistent No Reflow to Predict Adverse Clinical Outcomes Following Percutaneous Coronary Intervention

(2011) William Chan et al.   AMERICAN JOURNAL OF CARDIOLOGY

Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction

(2010) Renpei Kobatake et al.   HEART AND VESSELS

Myocardial No-Reflow in Humans

(2009) Giampaolo Niccoli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of Intra-Coronary Nicorandil Administration Prior to Reperfusion in Acute ST Segment Elevation Myocardial Infarction

(2008) Han Cheol Lee et al.   CIRCULATION JOURNAL